Author:
Biglan Kevin M.,Holloway Robert G.
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Neuroscience
Reference51 articles.
1. Temple RJ: A regulatory authority’s opinion about surrogate endpoints. In Clinical Measurement in Drug Evaluation. Edited by Nimmo WS, Tucker GT. New York: Wiley; 1995.
2. Schatzkin A: Understanding clinical trials: intermediate markers as surrogate endpoints in cancer research. Hematol Oncol Clin North Am 2000, 14:1–15.
3. De Gruttola V, Fleming T, Lin DY, Coombs R: Perspective: validating surrogate markers-are we being naive? J Infect Dis 1997, 175:237–246.
4. Wittes J, Lakatos E, Probstfield J: Surrogate endpoints in clinical trials: cardiovascular diseases. Stat Med 1989, 8:415–425.
5. Johnston KC: What are surrogate outcome measures and why do they fail in clinical research? Neuroepidemiology 2000, 18:167–173.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献